Yen, F.-S.; Wei, J.C.-C.; Sung, C.-Y.; Li, P.-Y.; Tsai, F.-J.; Hsu, C.-C.; Hwu, C.-M.
Impact of Adding GLP-1 Receptor Agonists to Insulin Therapy on Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Nationwide Cohort Study from Taiwan. Pharmaceuticals 2025, 18, 1368.
https://doi.org/10.3390/ph18091368
AMA Style
Yen F-S, Wei JC-C, Sung C-Y, Li P-Y, Tsai F-J, Hsu C-C, Hwu C-M.
Impact of Adding GLP-1 Receptor Agonists to Insulin Therapy on Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Nationwide Cohort Study from Taiwan. Pharmaceuticals. 2025; 18(9):1368.
https://doi.org/10.3390/ph18091368
Chicago/Turabian Style
Yen, Fu-Shun, James Cheng-Chung Wei, Chen-Yu Sung, Pei-Yun Li, Fuu-Jen Tsai, Chih-Cheng Hsu, and Chii-Min Hwu.
2025. "Impact of Adding GLP-1 Receptor Agonists to Insulin Therapy on Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Nationwide Cohort Study from Taiwan" Pharmaceuticals 18, no. 9: 1368.
https://doi.org/10.3390/ph18091368
APA Style
Yen, F.-S., Wei, J. C.-C., Sung, C.-Y., Li, P.-Y., Tsai, F.-J., Hsu, C.-C., & Hwu, C.-M.
(2025). Impact of Adding GLP-1 Receptor Agonists to Insulin Therapy on Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Nationwide Cohort Study from Taiwan. Pharmaceuticals, 18(9), 1368.
https://doi.org/10.3390/ph18091368